Demand for Hydroxychloroquine
Tablets for Treatment of Covid-19 to
Raise the Growth of
Hydroxychloroquine Sulphate Market
Research Nester released a report titled “Hydroxychloroquine Suphate Market:
Global Demand Analysis & Opportunity Outlook 2026” which delivers detailed
overview of the global hydroxychloroquine sulfate market in terms of market
segmentation by type, by application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers,
restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s
five force model.
The market for hydroxychloroquine sulfate is projected to grow at a CAGR of 5.7%
during the forecast period, i.e, 2020-2026. The market is anticipated to attain a
significantly high market value of USD 1,405.7 million by the end of 2026.
Hydroxychloroquine sulphate, also known as hydroxychloroquine, is an antimalarial
medication which is approved for the treatment and prevention of certain types of
diseases such as malaria, systemic lupus erythematosus, and rheumatoid arthritis
among several others. This medicine is listed on the World Health Organization’s List of
Essential Medicines as it is the safest and most effective medicines required in every
health system. The market is segmented by type, by application and by region, out of
which, the market for hydroxychloroquine is segmented into rheumatoid joint,
adolescent chronic joint, discoid & systemic lupus erythmatosus and skin lesions.
On the basis of region, the market is segmented into North America, Europe, Asia
Pacific, Latin America and Middle East & Africa. In the Asia Pacific region, the market in
China is predicted to hold the largest share in the global market by attaining a value of
USD 305.0 million by 2026.The market in North America is estimated to witness the
highest share in the market with the largest market in the United States, which further is
the projected to be the fastest growing market in the region at a CAGR of 6.3% du